Cargando…
Regulatory T cells as a therapeutic approach for inflammatory bowel disease
Foxp3(+) T regulatory (Treg) cells suppress inflammation and are essential for maintaining tissue homeostasis. A growing appreciation of tissue‐specific Treg functions has built interest in leveraging the endogenous suppressive mechanisms of these cells into cellular therapeutics in organ‐specific d...
Autores principales: | Laukova, Marcela, Glatman Zaretsky, Arielle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107179/ https://www.ncbi.nlm.nih.gov/pubmed/36562391 http://dx.doi.org/10.1002/eji.202250007 |
Ejemplares similares
-
Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022) -
Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer
por: Kurniawan, Henry, et al.
Publicado: (2020) -
The Vγ4/butyrophilin conspiracy: novel role of intraepithelial γδ T cells in chronic inflammatory bowel disease
por: Kabelitz, Dieter
Publicado: (2023) -
In vivo activation of transferred regulatory T cells specific for third‐party exogenous antigen controls GVH disease in mice
por: Martin, Gaëlle H., et al.
Publicado: (2013) -
Functional predictions from inference and observation in sequence-based inflammatory bowel disease research
por: Meyer, Folker, et al.
Publicado: (2012)